Comment on Nektar anticipates a big payday

Nektar anticipates a big payday

The Food and Drug Administration approved Movantik, or naloxegol, tablets for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain. Millions of patients take opioids for relief from chronic pain, but one undesirable side effect of opioids is that they bind to mu-receptors in the gastrointestinal tract and can lead to constipation. When Europe’s equivalent of the FDA agreed to review the drug’s application for approval last year, AstraZeneca paid Nektar $25million.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News